ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/07 | 1,100 | 1,124 | 1,058 | 1,074 | -7 | -0.6% | 2,035,400 |
2019/02/06 | 1,086 | 1,121 | 1,072 | 1,081 | +3 | +0.3% | 1,942,900 |
2019/02/05 | 1,150 | 1,155 | 1,068 | 1,078 | +11 | +1% | 3,809,700 |
2019/02/04 | 1,021 | 1,080 | 1,021 | 1,067 | +46 | +4.5% | 2,577,700 |
2019/02/01 | 1,026 | 1,047 | 1,008 | 1,021 | +8 | +0.8% | 1,994,900 |
2019/01/31 | 1,034 | 1,058 | 1,005 | 1,013 | +15 | +1.5% | 2,635,600 |
2019/01/30 | 1,040 | 1,052 | 985 | 998 | -124 | -11.1% | 5,491,800 |
2019/01/29 | 1,121 | 1,145 | 1,099 | 1,122 | -5 | -0.4% | 1,680,400 |
2019/01/28 | 1,195 | 1,202 | 1,115 | 1,127 | -60 | -5.1% | 2,332,800 |
2019/01/25 | 1,180 | 1,204 | 1,140 | 1,187 | +8 | +0.7% | 2,292,200 |
2019/01/24 | 1,209 | 1,222 | 1,175 | 1,179 | -44 | -3.6% | 2,709,700 |
2019/01/23 | 1,124 | 1,228 | 1,113 | 1,223 | +87 | +7.7% | 3,525,800 |
2019/01/22 | 1,163 | 1,192 | 1,117 | 1,136 | -30 | -2.6% | 3,110,600 |
2019/01/21 | 1,340 | 1,360 | 1,164 | 1,166 | -144 | -11% | 5,715,900 |
2019/01/18 | 1,196 | 1,310 | 1,196 | 1,310 | +116 | +9.7% | 5,010,400 |
2019/01/17 | 1,171 | 1,234 | 1,163 | 1,194 | +20 | +1.7% | 3,252,500 |
2019/01/16 | 1,190 | 1,227 | 1,161 | 1,174 | +7 | +0.6% | 3,384,600 |
2019/01/15 | 1,102 | 1,181 | 1,093 | 1,167 | +57 | +5.1% | 2,768,500 |
2019/01/11 | 1,157 | 1,187 | 1,092 | 1,110 | -47 | -4.1% | 3,824,400 |
2019/01/10 | 1,157 | 1,268 | 1,127 | 1,157 | -15 | -1.3% | 8,868,200 |
2019/01/09 | 1,135 | 1,216 | 1,123 | 1,172 | +94 | +8.7% | 14,034,000 |
2019/01/08 | 1,078 | 1,078 | 1,063 | 1,078 | +150 | +16.2% | 1,347,100 |
2019/01/07 | 907 | 935 | 898 | 928 | +64 | +7.4% | 2,183,200 |
2019/01/04 | 784 | 877 | 780 | 864 | +65 | +8.1% | 2,046,000 |
2018/12/28 | 803 | 837 | 794 | 799 | -16 | -2% | 1,514,100 |
2018/12/27 | 811 | 833 | 790 | 815 | +35 | +4.5% | 2,002,100 |
2018/12/26 | 778 | 808 | 761 | 780 | +28 | +3.7% | 1,998,900 |
2018/12/25 | 763 | 798 | 748 | 752 | -58 | -7.2% | 2,737,900 |
2018/12/21 | 818 | 847 | 798 | 810 | -22 | -2.6% | 2,778,700 |
2018/12/20 | 871 | 902 | 818 | 832 | -34 | -3.9% | 2,647,000 |
2018/12/19 | 877 | 897 | 851 | 866 | ±0 | ±0% | 1,588,700 |
2018/12/18 | 891 | 900 | 866 | 866 | -45 | -4.9% | 1,567,800 |
2018/12/17 | 970 | 972 | 905 | 911 | -65 | -6.7% | 1,790,900 |
2018/12/14 | 965 | 1,015 | 941 | 976 | +47 | +5.1% | 3,958,800 |
2018/12/13 | 970 | 974 | 890 | 929 | -19 | -2% | 3,428,000 |
2018/12/12 | 923 | 968 | 910 | 948 | +36 | +3.9% | 1,270,900 |
2018/12/11 | 940 | 958 | 903 | 912 | -16 | -1.7% | 1,201,300 |
2018/12/10 | 951 | 953 | 915 | 928 | -38 | -3.9% | 1,320,400 |
2018/12/07 | 987 | 1,003 | 960 | 966 | -11 | -1.1% | 1,152,700 |
2018/12/06 | 1,000 | 1,005 | 968 | 977 | -32 | -3.2% | 1,404,300 |
2018/12/05 | 1,030 | 1,044 | 1,004 | 1,009 | -51 | -4.8% | 1,423,800 |
2018/12/04 | 1,088 | 1,123 | 1,048 | 1,060 | -40 | -3.6% | 1,461,700 |
2018/12/03 | 1,130 | 1,163 | 1,097 | 1,100 | -5 | -0.5% | 2,100,600 |
2018/11/30 | 1,101 | 1,132 | 1,089 | 1,105 | +15 | +1.4% | 1,202,100 |
2018/11/29 | 1,129 | 1,137 | 1,085 | 1,090 | -18 | -1.6% | 1,450,300 |
2018/11/28 | 1,070 | 1,129 | 1,066 | 1,108 | +43 | +4% | 1,593,700 |
2018/11/27 | 1,062 | 1,103 | 1,055 | 1,065 | +13 | +1.2% | 1,366,200 |
2018/11/26 | 1,060 | 1,074 | 1,046 | 1,052 | -8 | -0.8% | 710,100 |
2018/11/22 | 1,050 | 1,077 | 1,041 | 1,060 | +13 | +1.2% | 796,900 |
2018/11/21 | 1,032 | 1,083 | 1,027 | 1,047 | +5 | +0.5% | 993,700 |
1551~
1600
件表示中 / 5113件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 89,500円 | +20.3% | - | 0.00% | 158.69倍 | 1.18倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 148,200円 | -2.4% | -52.3% | 3.85% | 17.74倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 211,000円 | +4.1% | -3.1% | 2.75% | 18.38倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ハートシード | 346,000円 | +174.2% | - | 0.00% | - | 10.38倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム